BRUSSELS SOUTH CHARLEROIBIOPARK

THE SCIENCE-DRIVEN BIOPARK AT THE HEART OF EUROPE

1 B€

YEARLY BIOTECH DEAL FLOW

Biopark

2500

HIGHLY SKILLED PEOPLE

Biopark

80

LIFE SCIENCE COMPANIES

Biopark

15

CLINICAL TRIALS SITES

Biopark

6

TECHNOLOGY PLATFORMS

Biopark

3

CROSS-FACULTY RESEARCH INSTITUTES

Biopark

MORE THAN 2,000 HIGHLY SKILLED PEOPLE FROM MORE THAN 30 COUNTRIES

OUR MISSION IS TO SUPPORT COMPANY GROWTH FROM INNOVATIVE START-UPS THROUGH TO GLOBAL PLAYERS

BIOPARK SKY VIEW

Testimonials

TESTIMONIALS

GREAT PLACE TO WORK

GREAT PLACE TO INVEST

GREAT PLACE TO GROW

MARGREET BROUWERSENIOR RESEARCH ASSISTANT AT Iteos Therapeutics

Testimonials

"As a former Research Assistant at ULB and now part of iTeos’ team, a biotech company headquartered here, I am delighted to see that the BioPark has attracted so many companies and people active in the life sciences sector and that it has evolved into a dynamic working environment with excellent amenities and social activities. The park’s unique cluster reinforces collaborations, stimulates knowledge sharing and creativity."

— Margreet Brouwer, Senior Research Assistant, Iteos Therapeutics

CHRIS BUYSEMANAGING PARTNER AT Fund+

Testimonials

"The BioPark’s cluster of innovative life sciences companies and their talented, multilingual and diverse work force together with the park’s state-of-the-art facilities make it an attractive place to invest. It provides an unique ecosystem of scientific, clinical and business expertise to progress early stage research and drug development through to stages offering excellent returns on investment with remarkable impact on society.”

— Chris Buyse, Managing Partner, Fund+

DENIS BEDORET PRESIDENT AT MaSTherCell Global

Testimonials

"The BioPark’s unique focus and expertise provide the perfect environment to grow your business into a fully-fledged, global company. The hands-on support we have received from the team, along with access to the BioPark’s outstanding services, have been a great help in establishing MTC as a distinguished, international cell therapy manufacturing company.”

— Denis Bedoret, President, MaSTherCell Global

WANT TO RECEIVE OUR MONTHLY NEWSLETTER?

NEWS

November 17th 2020

TheraVet launches a prospective multicentric clinical trial in canine osteosarcomaTheraVet S.A., the specialist of the osteo-articular diseases of small companion animals, announces the launch of a prospective multicentric clinical trial in canine osteosarcoma with BIOCERA-VET, The...

News

November 1st 2020

GenFlow Biosciences, a new gene therapy biotech joining Brussels South Charleroi BioParkGenFlow Biosciences develops a transformative new class of gene therapy that target the upstream biology of aging that will change the standard of care. Discover more on there website.

News

EVENTS

December 11th 2020

FORMATION HELSCI - IMAGERIEIMAGE-3.9 - L'ABC de l'analyse d'images biologiques La prochaine édition a lieu le 11 et 16 décembre 2020  

11.12.2020 / 9:00 > 5:00 PM Charleroi Gosselies Campus

Events

December 10th 2020

FORMATION HELSCI - QUALITE & REGLEMENTATIONQUALREG-1.3 - Les affaires réglementaires appliquées aux biomédicaments Cette formation vous permettra de rapidement naviguer dans la réglementation (affaires rég...

10.12.2020 / 9:00 > 5:00 PM Charleroi Gosselies Campus

Events